https://www.selleckchem.com/pr....oducts/Monensin-sodi
6 months, and only 11 cases out of them received the third-line therapy but no one responded. The change of CTC counts was identified to be correlated with therapy response. However all the five SCLC patients who were administered with the drugs according to the drug susceptibility test of CTCs for two cycles underwent progression of disease. The results showed that the responses of chemotherapy are very poor in later lines and the drug susceptibility test using CTCs primary cultured may not benefit the improvement o